ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,971Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 676

$471K Total Retail Price of All Prescriptions

Rank: 230 out of 676

402 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 7,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
FUROSEMIDE 435 366 1 4
METFORMIN HCL 343 287 2 8
OMEPRAZOLE 337 255 3 2
HYDROCODONE-ACETAMINOPHEN 335 211 S3 4 1
AMLODIPINE BESYLATE 320 267 5 3
SIMVASTATIN 278 242 6 6
POTASSIUM CHLORIDE 251 194 7 9
LISINOPRIL 233 162 8 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 221 147 9 16
ATENOLOL 215 160 10 25
CARVEDILOL 177 145 11 15
PRAVASTATIN SODIUM 172 140 12 11
GLIMEPIRIDE 165 122 13 30
ZOLPIDEM TARTRATE 165 124 13 21
ATORVASTATIN CALCIUM 159 113 15 20
SERTRALINE HCL 150 145 16 26
ACTOS 148 120 17 106
WARFARIN SODIUM 142 112 18 18
LEVOTHYROXINE SODIUM 136 117 19 7
MELOXICAM 130 97 20 13
TRAMADOL HCL 127 104 21 19
NEXIUM 124 101 22 23
METOPROLOL TARTRATE 122 106 23 22
GABAPENTIN 120 87 24 10
CIPROFLOXACIN HCL 112 80 25 45
CLOPIDOGREL 99 80 26 28
CITALOPRAM HBR 96 46 27 17
AMLODIPINE BESYLATE-BENAZEPRIL 94 86 28 44
TAMSULOSIN HCL 90 84 29 38
FENOFIBRATE 82 71 30 90
TIZANIDINE HCL 80 63 31 68
DIGOXIN 72 66 32 52
PIOGLITAZONE HCL 71 57 R 33 266
RANITIDINE HCL 70 47 34 27
METOPROLOL SUCCINATE 69 50 35 14
FAMOTIDINE 68 37 36 64
SPIRONOLACTONE 67 61 37 62
LOVASTATIN 65 48 38 33
HYDROCHLOROTHIAZIDE 63 40 39 12
ALLOPURINOL 62 60 40 31
PLAVIX 59 52 41 40
KLOR-CON 10 58 38 42 95
METFORMIN HCL ER 53 40 43 63
CARISOPRODOL 52 24 R 44 60
CLONIDINE HCL 51 33 45 32
FINASTERIDE 51 51 45 197
BENICAR HCT 50 36 47 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.